TNNI3 Interacting Kinase (TNNI3K) (Middle Region) Peptide
TNNI3K
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all TNNI3K products
- TNNI3K (TNNI3 Interacting Kinase (TNNI3K))
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-TNNI3K antibody (Catalog #: ARP48045_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- TNNI3K (TNNI3 Interacting Kinase (TNNI3K))
- Background
-
TNNI3K may play a role in cardiac physiology.
Alias Symbols: CARK, MGC142099, MGC33828
Protein Interaction Partner: ACTA1,ACTC1,AIP,FABP3,HADHB,MYBPC3,TNNI3,ACTA1,ACTC1,AIP,FABP3,HADHB,MYBPC3,TNNI3
Protein Size: 835 - Molecular Weight
- 93 kDa
- Gene ID
- 51086
- NCBI Accession
- NM_015978, NP_057062
-
You are here:
